Biologics Contract Development Market to Reach $14.46B by 2030 at 11% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Biologics Contract Development Market During 2026–2030?
The biologics contract development market size has seen substantial growth in recent years. This market is expected to expand from $8.55 billion in 2025 to $9.53 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. The increase observed in the past can be attributed to increasing biologics pipeline complexity, rising costs of in-house manufacturing, expansion of monoclonal antibody development, growth of early-stage biologics research, and increasing reliance on specialized cdmos.
The biologics contract development market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $14.46 billion, exhibiting a compound annual growth rate (CAGR) of 11.0%. This anticipated growth throughout the forecast period stems from factors such as a heightened need for accelerated biologics scale-up, augmented investments in sophisticated mammalian cell platforms, an expanding array of oncology biologics pipelines, a heightened emphasis on adaptable manufacturing capabilities, and the wider incorporation of digital bioprocess optimization. Key developments expected during this period involve a greater propensity for outsourcing biologics process development, an escalating requirement for scalable cell line development, broader implementation of single-use bioprocessing systems, the proliferation of integrated CDMO service paradigms, and a stronger concentration on accelerating development to clinic.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Factors Are Influencing The Growth Of The Biologics Contract Development Market?
The increasing incidence of long-term illnesses is projected to boost the biologics contract development market in the future. Chronic diseases are defined as conditions persisting for a year or more, necessitating continuous medical care. This growth in chronic disease instances fuels the need for new drug development, particularly biologics, consequently fostering the biologics contract development market. An illustrative example comes from September 2024, where reports from the UK’s Office for Health Improvement & Disparities indicated 3,940 excess deaths from chronic lower respiratory diseases in the first half of 2023, a 30% increase over anticipated figures. The annual total reached 5,363, an overall rise of 22%. Consequently, the growing occurrence of chronic diseases is set to stimulate expansion within the biologics contract development market.
What Are The Key Segment Divisions In The Biologics Contract Development Market Segment Structure?
The biologics contract development market covered in this report is segmented –
1) By Source: Microbial, Mammalian, Other Sources
2) By Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Other Indications
3) By Product Service: Cell Line Development, Process Development, Other Product Services
Subsegments:
1) By Microbial: Bacterial Sources, Yeast Sources, Fungal Sources
2) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Hybridoma Cells
3) By Other Sources: Plant-Based Systems, Insect Cell Systems, Algal Sources
Which Trends Are Influencing Demand In The Biologics Contract Development Market?
Major companies involved in biologics contract development are concentrating on incorporating data analytics into their operational frameworks. These companies are integrating digital technologies and advanced data analytics into biologics development to improve process oversight, data interpretation, and strategic decision-making, ultimately enhancing efficiency and productivity. For instance, in October 2023, WuXi Biologics, a China-based company specializing in biologics contract development and manufacturing, launched its WuXiUI high-productivity bioprocessing platform. This WuXiUI platform represents WuXi Biologics’ proprietary ultra-intensified intermittent-perfusion fed-batch system, which has been successfully implemented for internal use and in client-focused biologics development and manufacturing projects. It facilitates, among other functions, real-time tracking of crucial process parameters using integrated Process Analytical Technology tools, optimizing cell culture productivity, and predicting product quality and yield profiles under varying process conditions, provided suitable process data inputs are available.
Which Organizations Are Engaged In The Biologics Contract Development Market?
Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Syngene International Limited, Vibalogics GmbH, Yposkesi
Get The Full Biologics Contract Development Market Report:
Where Is The Biologics Contract Development Market Primarily Concentrated By Region?
North America was the largest region in the biologics contract development market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biologics Contract Development Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Biologics Contract Development Market 2026, By The Business Research Company
Biopharmaceuticals Contract Manufacturing Market Report 2026
Biologics Outsourcing Market Report 2026
https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report
Biologics Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
